Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Atopic Dermatitis
Interventions
DRUG

5-Methoxypsoralen

1,2 mg/kg 2 hours before UVA irradiation p.o. 3 times weekly for 5 weeks

DEVICE

UVA1 phototherapy

"Treatment 5 x week for 3 weeks (=15 irradiations). Determination of the UVA 1 MED prior to treatment. Start with 1 MED. Increments of the UVA 1 dose in 20 % steps until a maximal dose of 70 J/cm2 in the absence of an erythemal reaction and by good tolerability.~No maintenance therapy except emollients."

Trial Locations (1)

1090

Medical University of Vienna; University Clinic of Dermatology; Division of Special and Environmental Dermatology, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00533195 - Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis | Biotech Hunter | Biotech Hunter